Back
SPDR® S&P Capital Markets ETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
60
KCE
SPDR® S&P Capital Markets ETF
Last Price:
125.90
Seasonality Move:
4.69%
Sell
33
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
60
SPDR® S&P Capital Markets ETF (KCE)
is a Buy
Is SPDR® S&P Capital Markets ETF a Buy, Sell or Hold?
- The current SPDR® S&P Capital Markets ETF [KCE] share price is $126.01. The Score for KCE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KCE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KCE Stock Price Chart
What is SPDR® S&P Capital Markets ETF's stock price today?
-
The SPDR® S&P Capital Markets ETF share price today is $126.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
KCE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.64 | Buy |
Relative Strength Index (14 RSI): | 70.75 | Buy |
Chaikin Money Flow: | 111570 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (117.56 - 122.02) | Buy |
Bollinger Bands (100): | (109.61 - 118.89) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62 | Buy |
Chaikin Money Flow: | 402350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.19 - 44.69) | Buy |
Bollinger Bands (100): | (30.3 - 45.36) | Buy |
KCE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.18 | Buy |
20-day SMA: | 120.14 | Buy |
50-day SMA: | 118.17 | Buy |
200-day SMA: | 108.79 | Buy |
8-day EMA: | 122.21 | Buy |
20-day EMA: | 120.26 | Buy |
50-day EMA: | 117.8 | Buy |
200-day EMA: | 108.8 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.33 | Buy |
20-day SMA: | 42.39 | Buy |
50-day SMA: | 43.82 | Buy |
200-day SMA: | 26.96 | Buy |
8-day EMA: | 43.04 | Buy |
20-day EMA: | 42.7 | Buy |
50-day EMA: | 41.84 | Buy |
200-day EMA: | 30.49 | Buy |
SPDR® S&P Capital Markets ETF Earnings Growth & KCE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
SPDR® S&P Capital Markets ETF Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |